×
Thursday, April 9, 2026

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages DENTSPLY SIRONA Inc. (XRAY) Investors with Significant Losses to Contact Firm's Attorneys, XRAY's Former CFO "Departs" Moderna Days After DENTSPLY Announce - GuruFocus.com

PR Newswire

SAN FRANCISCO , May 12, 2022 /PRNewswire/ -- Hagens Berman urges DENTSPLY SIRONA, Inc. (NASDAQ: XRAY) investors with significant losses to submit your losses now.

Visit: www.hbsslaw.com/investor-fraud/XRAY
Contact An Attorney Now: [email protected]
844-916-0895

DENTSPLY SIRONA, Inc. (XRAY) Investigation:

The investigation focuses on DENTSPLY's assurances that its financial statements fairly presented in all material respects the financial condition of the company.

The assurances began to come into question on Apr. 11, 2022 when DENTSPLY announced that CFO Jorge Gomez resigned to take another job and Moderna (MRNA) announced Gomez was hired as its CFO effective May 9, 2022.

On Apr. 19, 2022, DENTSPLY announced that it fired CEO Donald M. Casey Jr. and that he ceased to serve on the company's Board of Directors, both effective immediately.

On May 10, 2022, DENTSPLY announced that its audit committee commenced an internal investigation in March 2022, before Gomez resigned and before the company fired Casey. DENTSPLY said: (1) it would not timely file its quarterly financial statements for the quarter ended March 31, 2022; (2) it commenced an internal investigation of allegations regarding certain financial matters submitted by current and former company employees; (3) its investigation is focused on its use of incentives to sell products to distributors in Q3 and Q4 2021 and whether those incentives were properly accounted for and adequately disclosed in SEC...



Read Full Story: https://www.gurufocus.com/news/1772910/hagens-berman-national-trial-attorneys...